SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,800,238 | -4.7% | 65,297 | +3.9% | 0.91% | +1.8% |
| Q2 2023 | $1,888,610 | -17.0% | 62,828 | +0.1% | 0.89% | -21.6% |
| Q1 2023 | $2,274,882 | +101095.8% | 62,790 | -0.4% | 1.14% | -1.0% |
| Q4 2022 | $2,248 | -99.9% | 63,020 | -0.7% | 1.15% | -2.2% |
| Q3 2022 | $2,148,000 | +21.1% | 63,468 | +3.4% | 1.18% | +25.7% |
| Q2 2022 | $1,774,000 | -10.7% | 61,352 | -0.2% | 0.94% | +1.1% |
| Q1 2022 | $1,986,000 | -37.4% | 61,461 | -43.5% | 0.93% | -29.1% |
| Q4 2021 | $3,174,000 | +9.3% | 108,862 | -0.0% | 1.31% | -0.6% |
| Q3 2021 | $2,904,000 | -31.5% | 108,884 | -21.0% | 1.32% | -8.9% |
| Q2 2021 | $4,242,000 | +13.8% | 137,782 | -3.2% | 1.45% | +17.1% |
| Q1 2021 | $3,727,000 | +3.0% | 142,363 | -1.0% | 1.24% | -10.1% |
| Q4 2020 | $3,618,000 | +19.5% | 143,813 | -1.0% | 1.37% | -5.0% |
| Q3 2020 | $3,028,000 | +3.0% | 145,309 | +17.4% | 1.45% | +7.2% |
| Q2 2020 | $2,940,000 | +33.5% | 123,774 | +1.1% | 1.35% | +26.5% |
| Q1 2020 | $2,203,000 | -14.1% | 122,483 | +13.2% | 1.07% | +1.0% |
| Q4 2019 | $2,566,000 | +5.9% | 108,198 | +22.8% | 1.06% | +1.2% |
| Q3 2019 | $2,422,000 | +6.1% | 88,126 | +27.7% | 1.04% | -17.0% |
| Q2 2019 | $2,283,000 | -5.1% | 69,000 | +0.5% | 1.26% | -10.2% |
| Q1 2019 | $2,406,000 | +40.9% | 68,662 | +33.6% | 1.40% | +25.9% |
| Q4 2018 | $1,708,000 | -26.0% | 51,406 | +12.1% | 1.11% | -22.4% |
| Q3 2018 | $2,308,000 | -19.3% | 45,843 | -4.1% | 1.43% | -20.7% |
| Q2 2018 | $2,861,000 | +26.5% | 47,795 | -3.2% | 1.81% | +18.8% |
| Q1 2018 | $2,262,000 | +22.3% | 49,390 | +6.5% | 1.52% | +13.3% |
| Q4 2017 | $1,849,000 | -0.4% | 46,395 | 0.0% | 1.34% | -3.2% |
| Q3 2017 | $1,856,000 | +1.0% | 46,395 | +8.8% | 1.39% | -9.6% |
| Q2 2017 | $1,838,000 | – | 42,655 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |